Sertraline HCl price index

Sertraline HCl price December 2025 and outlook (see chart below)

• India:US$59.52/KG, -2.8% down

Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.

Sertraline HCl price index

This post is a summary of the Sertraline HCl price developments. The price developments of Sertraline HCl are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Sertraline HCl price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.

The outlook for Sertraline HCl prices is generated from different inputs including:

• Very recent price developments of immediate cost drivers of Sertraline HCl prices
• Recent price developments of underlying feedstocks which drive the price of Sertraline HCl
• Market futures for both cost drives and feedstocks of Sertraline HCl prices
• Adjustment of current supply/demand imbalances in the Sertraline HCl market
• Longer term trends in likely demand conditions

What is Sertraline HCl and what is it used for

Sertraline HCl is the hydrochloride salt form of the antidepressant medication sertraline, which belongs to the selective serotonin reuptake inhibitor (SSRI) class. It is prescribed for conditions such as major depressive disorder, obsessive-compulsive disorder (OCD), panic disorder, post-traumatic stress disorder (PTSD), social anxiety disorder, and in some jurisdictions premenstrual dysphoric disorder (PMDD). The mechanism involves increasing serotonin levels in the brain by inhibiting its re-uptake into neurons.

How is Sertraline HCl used

Sertraline HCl is administered orally, typically once daily, at a dose and schedule determined by a prescribing physician based on the specific condition, the patient’s age, and other clinical factors. It can be taken with or without food. For many patients the treatment continues for months after symptom relief to reduce risk of relapse. Sudden cessation is not recommended because withdrawal or discontinuation symptoms may occur; gradual dose reduction under medical supervision is advised.

How large is the global market for Sertraline HCl and where is it produced

The global market size for Sertraline HCl (and its active pharmaceutical ingredient, API) has been estimated at around USD 1.2 billion in 2024 for the API segment alone, with forecasts to reach about USD 1.8 billion by 2033. Another report suggests that the tablet/formulation market may have reached approximately USD 1.9 billion in 2023 and is projected to grow to about USD 2.6 billion by 2032. In terms of geography, North America leads in share (about 40 % of API market revenue in 2026), followed by Europe (30 %) and Asia-Pacific (20 %). Regarding production and sourcing, India is a major exporter of Sertraline HCl APIs, reportedly supplying the vast majority of shipments globally. Pharmaceutical companies with production facilities include large generic/API manufacturers which operate in India, the United States, Europe and other regions.